GlassScriptPhysician profile
Amir Riaz
NPI 1760943757
$1,410.11
in general payments reported to CMS, 2019-2025
16 companies · $716 in 2025
The $716 reported for 2025 was more than what 80% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $100 · 2020: $22.50 · 2022: $146 · 2023: $38.01 · 2024: $388 · 2025: $716.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,058 · Education: $84.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,057.69 |
| Education | $84.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $373.54 | 2023-2025 | |
| Novo Nordisk INC | $149.84 | 2025 | Wegovy |
| Intuitive Surgical, INC. | $132.01 | 2025 | |
| Janssen Biotech, INC. | $131.03 | 2025 | Tremfya |
| Phathom Pharmaceuticals, INC. | $124.70 | 2024 | Voquezna |
| E.R. Squibb & Sons, L.L.C. | $116.35 | 2022 | |
| Boston Scientific Corporation | $100.15 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $68.52 | 2024-2025 | Entyvio |
| Ipsen Biopharmaceuticals, INC | $44.78 | 2024 | Iqirvo |
| Redhill Biopharma INC. | $39.34 | 2023-2024 | Talicia, Aemcolo |
| Neurelis, INC. | $32.00 | 2025 | Valtoco |
| Ardelyx, INC. | $25.35 | 2024 | Ibsrela |
| Gilead Sciences, INC. | $22.50 | 2020 | |
| Intercept Pharmaceuticals, INC. | $20.58 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $15.13 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $14.29 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amir Riaz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.